Podcast Episodes

Crowdstrike Q2 2026

Here's a brief run through Crowdstrike Q2 2026 numbers. Crowdstrike is a cyber security stock.

In this epsiode, i walk through the numbers and opine o…

1 year, 1 month ago

Transpower: H1 25 and other things

In this episode, i zero in on transpower following large off market trades in fhe last few trading sessions. I also do some napkin math if it gets pa…

1 year, 1 month ago

Twitterspace with the MD/CEO of The Initiates Plc

Here is a recording of the greentickertale twitter space with Mr Reuben Ossai the MD/CEO of The Initiates Plc (TIP).

TIP is a waste management firm li…

1 year, 1 month ago

Prestige Assurance H1 2025

In this episode, i walk through H1 2025 results for Prestige Assurance. H1 2025 means the first 6 months of 2025 for the company.

As always, please no…

1 year, 1 month ago

May and Baker H1 2025

May and Baker is one of the smaller players of the pharma players listed on the NGX.

Here's my walk through its H1 2025 results.

1 year, 1 month ago

Neimeth H1 2025

Neimeth is the smallest of the big 4 pharma firms listed on the NGX. Here are my views on its H1 2025 earnings and the company's share price.

1 year, 1 month ago

Mecure H1 2025

Mecure is one of the 5 listed players in the pharma space on the NGX.

In fhis episode i discuss its H1 2025 earnings: Revenue split and pain points.

1 year, 1 month ago

Fidson H1 2025 review

Here's my first of 3 episodes on pharma firms H1 2025 earnings on the NGX.

I walk through Fidson H1 2025 earnings as well as my near and mid term pric…

1 year, 1 month ago

Chams 2025 rights issue

In this epsiode i share my thoughts on Chams ongojng rights issue. i also touch brielfy on its H1 2025 results and my thoughts on the firm as a whole…

1 year, 1 month ago

MTN Nigeria H1 2025

Here's a walk through MTN Nigeria's H1 2025 results. MTN is Nigeria's biggest telco operator with over 80 million subscribers.

1 year, 1 month ago